Kia's Lego-like PV5 with 16 variants to hit market in July
Kia Corp., South Korea’s second-largest carmaker under Hyundai Motor Group, is set to redefine mobility solutions with its modular electric pl...
LG Energy, GM’s JV Ultium Cells to retrofit Tennessee plant to produce LFP batteries
Ultium Cells LLC, a battery joint venture between South Korea’s LG Energy Solution Ltd. and General Motors Co., will upgrade its battery cell ...
Kia to make, sell China-launched EV5 in Korea to keep top spot
Kia Corp., South Korea’s second-largest automaker, plans to manufacture and sell the EV5, its first China-made all-electric vehicle, at home t...
Loss-making Lotte Chemical to sell water treatment unit to Synopex
Lotte Chemical Corp., South Korea’s second-largest petrochemical company grappling with mounting losses amid a prolonged industry downturn, wi...
Hanwha Q Cells eyes tandem cell mass production in 2027
Hanwha Q Cells Co., the solar panel manufacturing unit of South Korea's Hanwha Solutions Corp., is expected to commercialize tandem modules by 2027,...
South Korea’s Rznomics inks $1.3 bn out-licensing deal with Eli Lilly
Rznomics Inc., a South Korean RNA therapeutics developer, has signed an agreement worth more than $1.3 billion with US pharmaceutical giant Eli Lill...
OCI to build $265 mn solar cell plant in Texas, expects $80 mn tax credit
South Korean solar cell company OCI Holdings Co. said on Thursday it will build a solar cell manufacturing plant in Texas through its US subsidiary ...
SK On to supply 100 GWh of EV batteries to Nissan
SK On Co. has landed a deal to supply nearly 100 gigawatt hours (GWh) of electric vehicle batteries to Japanese carmaker Nissan Motor Co., which cou...
Hyundai Motor to build fuel cell plant in South Korea
Hyundai Motor Co. will build a local fuel cell plant in South Korea, accelerating its bid to create an entire hydrogen fuel cell value chain in line...
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Korea’s OCI, Israel’s Arava Power to jointly build solar cell plant in Texas
OCI Energy Co., a US subsidiary of South Korea’s OCI Holdings Co., and Israel’s Arava Power will jointly build a solar cell power plant ...
SK Ecoplant seeks to sell waste treatment business for $1.4 billion
SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...
LG Chem embarks on sale of dermal filler business worth $343 million
LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...
Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe
South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...
Hanwha Q Cells sells two solar power plant projects in US
Hanwha Q Cells Co., a solar panel manufacturing arm of South Korea's Hanwha Solutions Corp., said on Wednesday that it sold its two large-scale sola...
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
SK Pharmteco bags obesity treatment deal worth up to $1.4 bn
SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
LG Energy set to acquire GM’s $1 bn stake in Ultium JV plant in Michigan
South Korea’s LG Energy Solution Ltd. plans to acquire General Motors Co.’s stake in their battery joint venture plant in Lansing, Michi...
Hanwha Q cells’ US subsidiary EnFin raises $321 mn through ABS
Hanwha Q Cells Co., the solar power unit of South Korea’s chemicals-to-defense conglomerate Hanwha Group known as Qcells in overseas markets, ...
LG Energy to supply 2170-type cells to Bear Robotics
South Korea’s LG Energy Solution Ltd. said on Monday it has signed an initial agreement to supply cylindrical battery cells to Bear Robotics I...
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Hanwha Q Cells, OCI to benefit from expanded US CHIPS Act subsidies
South Korean solar cell companies such as Hanwha Q Cells Co. and OCI Holdings Co. are set to benefit from expanded subsidies covered by the US CHIPS...
DS Dansuk wins $750 mn SAF material order from Phillips 66
South Korea's DS Dansuk Co., which operates bioenergy, battery, and plastic recycling businesses, said on Monday it signed a 1 trillion won ($750 mi...
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
LG Energy, Stellantis’ EV battery JV in Canada mass-produces modules
LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, said on Wednesday its joint venture in Canada with m...
LG Energy to supply batteries for Ford's electric commercial vehicles
LG Energy Solution Ltd., the world’s third-largest electric vehicle battery manufacturer, is set to supply battery cells and modules to US For...
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
